[Transplant-induced recovery from 6-OHDA lesions of the nigro-striatal dopamine neurons in mice]. 1988

K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
Department of Neurosurgery, Osaka University Medical School, Japan.

Attempts to reconstruct the damaged nigrostriatal pathway in experimental models of Parkinson disease have thus far been carried out in animals with neurotoxically induced dopamine deficiency. Our study established that unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal-dopamine (DA) neurons produced a well-characterized functional asymmetry in the behavior of C57BL/6 (H-2b) mice. The intraperitoneal administration of methamphetamine induced ipsilateral rotation at 7-20 turns/min. 11 x 10(6) syngenic DA-rich cells of embryonic ventral mesencephalon were stereotaxically transplanted in the caudate-putamen. A complete recovery of methamphetamine-induced rotational response was produced around the 60-th day after the syngenic cell suspension graft. And a complete compensation of the rotational response was also brought about with the DA-rich cells from embryonic ventral mesencephalon (crown-rump length; 10-13 mm) of allogenic C 3 H/HeN (H-2k) mice. The FACS IV analysis revealed no H-2 (Kk and Iak) antigens before transplantation of these embryonic cells. Immunohistochemistry showed that the dopaminergic fibers had grown predominantly into the ipsilateral caudate-putamen. These results provide evidence of integration of syngenic and allogenic grafts and host tissue. And the immunological response in the transplanted brain are under investigation.

UI MeSH Term Description Entries
D008694 Methamphetamine A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed. Deoxyephedrine,Desoxyephedrine,Desoxyn,Madrine,Metamfetamine,Methamphetamine Hydrochloride,Methylamphetamine,N-Methylamphetamine,Hydrochloride, Methamphetamine,N Methylamphetamine
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010302 Parkinson Disease, Secondary Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42) Atherosclerotic Parkinsonism,Secondary Parkinsonism,Symptomatic Parkinson Disease,Parkinson Disease, Secondary Vascular,Parkinson Disease, Symptomatic,Parkinsonism, Secondary,Parkinsonism, Symptomatic,Secondary Vascular Parkinson Disease,Parkinsonism, Atherosclerotic,Secondary Parkinson Disease,Symptomatic Parkinsonism
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D005260 Female Females
D006892 Hydroxydopamines Dopamines with a hydroxy group substituted in one or more positions. Hydroxydopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013378 Substantia Nigra The black substance in the ventral midbrain or the nucleus of cells containing the black substance. These cells produce DOPAMINE, an important neurotransmitter in regulation of the sensorimotor system and mood. The dark colored MELANIN is a by-product of dopamine synthesis. Nigra, Substantia,Nigras, Substantia,Substantia Nigras

Related Publications

K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
December 1995, Brain research,
K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
December 1978, Pharmacology, biochemistry, and behavior,
K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
August 1973, Journal of neurochemistry,
K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
January 1974, Advances in neurology,
K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
June 1990, Canadian journal of psychology,
K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
January 1971, Acta physiologica Scandinavica. Supplementum,
K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
February 2012, Brain research bulletin,
K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
August 1987, Brain research bulletin,
K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
July 1972, Journal of neurochemistry,
K Shimizu, and N Tsuda, and Y Matsui, and Y Okamoto, and Y Miyao, and M Yamada, and T Ikeda, and H Hatanaka, and H Mogami
January 1975, Journal of neural transmission,
Copied contents to your clipboard!